Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001490978-25-000047
Filing Date
2025-04-24
Accepted
2025-04-24 07:58:54
Documents
22
Period of Report
2025-04-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A sdgr-20250423.htm   iXBRL DEF 14A 1185957
3 sdgr-20250423_g1.jpg GRAPHIC 572512
4 sdgr-20250423_g2.jpg GRAPHIC 87870
5 sdgr-20250423_g3.jpg GRAPHIC 147660
6 sdgr-20250423_g4.jpg GRAPHIC 123596
7 sdgr-20250423_g5.jpg GRAPHIC 367509
8 sdgr-20250423_g6.jpg GRAPHIC 486103
9 sdgr-20250423_g7.jpg GRAPHIC 195970
10 sdgr-20250423_g8.jpg GRAPHIC 437514
11 sdgr-20250423_g9.jpg GRAPHIC 195827
  Complete submission text file 0001490978-25-000047.txt   8229647

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sdgr-20250423.xsd EX-101.SCH 930
24 EXTRACTED XBRL INSTANCE DOCUMENT sdgr-20250423_htm.xml XML 251314
Mailing Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036
Business Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036 503-299-1150
Schrodinger, Inc. (Filer) CIK: 0001490978 (see all company filings)

EIN.: 954284541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39206 | Film No.: 25863613
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)